Safety, Tolerability and Pharmacokinetic Profile of SYL1801 Eye Drops

Exclusion Criteria

• •Pregnant or breastfeeding females or those with a positive pregnancy test. Females of childbearing potential who will not use a medically acceptable contraceptive method
• •Current relevant diseases according to the investigator's judgement.
• •Previous relevant chronic processes according to the investigator's judgement
• •Relevant visual alterations according to the investigator's judgement
• •Administration of systemic medications
• •Case history of hypersensitivity to medicinal products or any other allergic process
• •Participation in any clinical study with an investigational drug/device within 3 months prior to the first day of dosing.